We collect cookies for vital website function and to better serve our customers. By continuing to browse you agree to the storing of cookies on your device. See our privacy policy for details.

AGI-5198

Item № 14624
CAS № 1355326-35-0
Purity ≥98%
product image
                (CAS 1355326-35-0)
SIZE PRICE QUANTITY SUBTOTAL
CART TOTAL
     1 mg $75.00 0.00
     5 mg $206.00 0.00
     10 mg $338.00 0.00
     25 mg $656.00 0.00

Pricing updated 2019-04-24. Prices are subject to change without notice.

Description

Isocitrate dehydrogenases (IDHs) are nicotinamide adenine dinucleotide (NAD+) and NAD phosphate (NADP+)-dependent enzymes in the tricarboxylic acid cycle that catalyze oxidative decarboxylation of isocitrate producing a-ketoglutarate (2-OG) and carbon dioxide. IDH1 and IDH2 are mutated in >70% of lower grade gliomas.1 The most common mutations map to arginine residues in the catalytic pockets of IDH1 (R132) or IDH2 (R140 and R172) and impart new gain of function catalytic activity leading to the NADPH-dependent conversion of 2-OG to 2-hydroxyglutarate (2-HG).2,3,4 AGI-5198 is a potent, selective inhibitor of IDH1 R132H and R132C mutants in vitro with IC50 values of 0.07 and 0.16 µM, respectively, but not wild-type IDH1, wild-type IDH2, or IDH2 mutants (IC50s > 100 μM).5 AGI-5198 has been shown to have anti-tumor efficacy in the TS603 glioma cell line and to lower tumor 2‑HG production in HT1080 and U87MG cells with IC50 values of 0.48 and 0.07 µM, respectively.6 In R132H-IDH1 glioma xenografts, AGI-5198 (450 mg/kg/day) caused 50-60% growth inhibition over a treatment period of three weeks with no affect in the growth of IDH1 wild-type glioma xenografts.5 Under conditions of near complete 2-HG inhibition, AGI-5198 can induce demethylation of histone H3K9me3 and expression of genes associated with gliogenic differentiation.5

Recommended Products

Related Products
View Related Product Categories
Technical Information
Formal Name
N-[2-(cyclohexylamino)-1-(2-methylphenyl)-2-oxoethyl]-N-(3-fluorophenyl)-2-methyl-1H-imidazole-1-acetamide
CAS Number
1355326-35-0
Molecular Formula
C27H31FN4O2
Formula Weight
462.6
Purity
≥98%
Formulation
A crystalline solid
SMILES
O=C(C(C1=C(C)C=CC=C1)N(C2=CC(F)=CC=C2)C(CN3C=CN=C3C)=O)NC4CCCCC4
InChI Code
InChI=1S/C27H31FN4O2/c1-19-9-6-7-14-24(19)26(27(34)30-22-11-4-3-5-12-22)32(23-13-8-10-21(28)17-23)25(33)18-31-16-15-29-20(31)2/h6-10,13-17,22,26H,3-5,11-12,18H2,1-2H3,(H,30,34)
InChI Key
FNYGWXSATBUBER-UHFFFAOYSA-N

Warning - this product is not for human or veterinary use.

Shipping & Storage
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Stability
≥ 2 years
Downloads & Resources
Product Downloads

Download Product Insert

Download Safety Data Sheet (SDS)

Download free InChI Key generation software

Additional Information

View the Cayman Structure Database for chemical structure definitions for many Cayman products

Get Batch-Specific Data and Documents by Batch Number

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data pack, and GC-MS data.

References & Product Citations
Product Description References

1. Turcan, S., Rohle, D., Goenka, A., et al. IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype Nature 483(7390), 479-483 (2012).

2. Reitman, Z.J., and Yan, H. Isocitrate dehydrogenase 1 and 2 mutations in cancer: Alterations at a crossroads of cellular metabolism Journal of the National Cancer Institute 102(13), 932-941 (2010).

3. Dang, L., White, D.W., Gross, S., et al. Cancer-associated IDH1 mutations produce 2-hydroxyglutarate Nature 462(7274), 739-744 (2009).

4. Koivunen, P., Lee, S., Duncan, C.G., et al. Transformation by the (R)-enantiomer of 2-hydroxyglutarate linked to EGLN activation Nature 483(7390), 484-488 (2012).

5. Rohle, D., Popovici-Muller, J., Palaskas, N., et al. An inhibitor of mutant IDH1 delays growth and promotes differentiation on glioma cells Science 340(6132), 626-630 (2013).

6. Popovici-Muller, J., Saunders, J.O., Salituro, F.G., et al. Discovery of the first potent inhibitors of mutant IDH1 that lower tumor 2-HG in vivo ACS Med.Chem.Lett. 3(10), 850-855 (2012).

Technical Support
Contact Us
  • Toll Free Phone (USA and Canada Only): (888) 526-5351
  • Direct Phone: (734) 975-3888
Cayman Contract Services

We work with scientists to accelerate their research, drug discovery, and drug development needs through our expertise in the following areas:

Cayman Chemical

1180 East Ellsworth Road

Ann Arbor, Michigan 48108 USA

Toll Free: (800) 364-9897

(USA and Canada Only)

Fax: (734) 971-3640